Second-hand smoke-induced cardiac fibrosis is related to the Fas death receptor apoptotic pathway without mitochondria-dependent pathway involvement in rats by Kuo,  W.W. et al.
Second-hand smoke (SHS), a mixture of smog
produced from a burning cigarette and exhaled
smoke, contains thousands of chemical con-
stituents, most of which are harmful and cause
human diseases such as lung cancer and cardio-
vascular disease (Boyle and Maisonneuve 1995;
Bronnum-Hansen 2000; De Cesaris et al.
1992; Haugen 2002; MacDougall et al. 1983).
However, most studies on this subject focus on
the association of SHS with respiratory symp-
toms, impaired lung function, and increased
bronchial responsiveness. Actually, epidemio-
logic studies have showed that exposure to SHS
increases the incidence of cardiac disease 4-fold
(Ciruzzi et al. 1998; Stefanadis et al. 1998), and
the mortality of cardiac failure among passive
smokers is 38% higher than in those who do
not smoke or who are not exposed to SHS
(Baud et al. 1991; Ecanow and Blake 1978).
Pope et al. (2001) found that 2 hr of exposure
to SHS significantly destroyed cardiac auto-
nomic function, as evidenced by decrements in
heart rate variability in 16 adult nonsmokers.
However, so far the mechanisms behind car-
diac disease in subjects exposed to SHS are
poorly understood.
Apoptosis is a recognized mechanism for
the elimination of redundant cells, although it
may also inhibit cell proliferation. In fact, it
has been suggested that apoptosis plays a criti-
cal role in the pathogenesis of human diseases,
including cardiac disorders (Haunstetter and
Izumo 1998). Apoptosis has been reported to
contribute to the loss of cardiomyocytes, after
which the collagen secreted by fibroblasts
replaces the space of damaged cardiomyocytes
in cardiomyopathy. Hence, the fibrosis fol-
lowing apoptosis is recognized as a predictor
of adverse outcomes in subjects with cardio-
myopathy (Kim and Iwao 2000; Narula et al.
1996). Therefore, the evaluation of the apop-
tosis and/or ﬁbrosis process could be an excel-
lent way of predicting the development of
cardiomyopathy induced by SHS, although
the specificity of the related signaling path-
ways involved in the development of apoptosis
and/or ﬁbrosis needs to be identiﬁed.
The induction of apoptosis is associated
with the activation of aspartate-speciﬁc cysteine
protease, including caspase-3 (Fernandes-
Alnemri et al. 1994). Several studies have
demonstrated that mitochondria may play an
important role in apoptosis by releasing
cytochrome c and activating caspase-9, which
activates caspase-3 that is responsible for
DNA-cleavage action (Liu et al. 1996; Reed
and Paternostro 1999). In end-stage car-
diomyopathy, cytosolic cytochrome c is also
accumulated (Narula et al. 1999). In addition,
the death-receptor–induced apoptotic path-
way is reportedly involved in the pathogenesis
of cardiac disease (Scheubel et al. 2002). This
pathway is initiated by death-receptor ago-
nists, including the Fas ligand. After ligand
binding, Fas receptor oligomerization results
in the activation of caspase-8, which is
upstream of caspase-3, causing the activation
of apoptosis (Haunstetter and Izumo 1998).
Therefore, as a common component of apop-
totic signaling, caspase-3 mediates both mito-
chondria-dependent and death-receptor–
dependent apoptotic pathways. Furthermore,
the down-regulation of a survival pathway is
another possible factor in the promotion of
apoptosis in cells. In cardiomyocytes, insulin-
like growth factor-1 (IGF-1), the survival fac-
tor through which IGF-1 receptor (IGF-1R)
activates the phosphatidylinositol-3 kinase/
protein kinase B (Parrizas et al. 1997) and the
Ras-Raf-MEK-ERK (Ras–Raf–mitogen-acti-
vated protein kinase–extracellular receptor
kinase) pathways, should be taken into consid-
eration for preventing myocyte apoptosis
(Hoshijima et al. 1998). Particularly, activated
PI3K enhances the phosphorylation of Akt
(Simoncini et al. 2000), which in turn regu-
lates the activity of Bad and BCl2 to control
the apoptosis of cardiomyocytes (Campbell
et al. 2001).
To understand whether the effects of SHS
on rat hearts are mediated through activating
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Exposure to environmental tobacco smoke has been epidemiologically linked to heart disease
among nonsmokers. However, the molecular mechanism behind the pathogenesis of cardiac disease
is unknown. In this study, we found that Wistar rats, exposed to tobacco cigarette smoke at doses
of 5, 10, or 15 cigarettes for 30 min twice a day for 1 month, had a dose-dependently reduced heart
weight to body weight ratio and enhanced interstitial fibrosis as identified by histopathologic analy-
sis. The mRNA and activity of matrix metalloprotease-2 (MMP-2), representing the progress of
cardiac remodeling, were also elevated in the heart. In addition, we used reverse-transcriptase poly-
merase chain reaction and Western blotting to demonstrate significantly increased levels of the
apoptotic effecter caspase-3 in treated animal hearts. Dose-dependently elevated mRNA and pro-
tein levels of Fas, and promoted apoptotic initiator caspase-8 (active form), a molecule of a death-
receptor–dependent pathway, coupled with unaltered or decreased levels of cytosolic cytochrome c
and the apoptotic initiator caspase-9 (active form), molecules of mitochondria-dependent pathways,
may be indicative of cardiac apoptosis, which is Fas death-receptor apoptotic-signaling dependent,
but not mitochondria pathway dependent in rats exposed to second-hand smoke (SHS). With
regard to the regulation of survival pathway, using dot blotting, we found cardiac insulin-like
growth factor-1 (IGF-1) and IGF-1 receptor mRNA levels to be significantly increased, indicating
that compensative effects of IGF-1 survival signaling could occur. In conclusion, we found that the
effects of SHS on cardiomyocyte are mediated by the Fas death-receptor–dependent apoptotic path-
way and might be related to the epidemiologic incidence of cardiac disease of SHS-exposed non-
smokers. Key words: cardiac survival IGF-1 signaling, caspases, death-receptor–dependent pathway,
mitochondria-dependent pathway, second-hand smoke (SHS). Environ Health Perspect
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apoptotic pathways, including mitochondria-
dependent and Fas death-receptor–dependent
signalings, or through suppressing survival
pathways, we examined the cardiac levels of
signaling proteins and gene expression in these
pathways by performing reverse-transcriptase
polymerase chain reaction (RT-PCR),
Western blotting, or dot blotting. We used
these results to explore the molecular mecha-
nisms of the pathogenesis of cardiac disease
induced by cigarette smoke.
Materials and Methods
Animal model and cigarette smoke exposures.
We purchased male Wistar rats (6 weeks of
age; body weight, 120 ± 10 g) from National
Science Council Animal Center (Taipei,
Taiwan). The animals were housed six per
cage in an environmentally controlled animal
room, and water was provided ad libitum. All
animals were handled according to the guide-
lines of the Taiwan Society for Laboratory
Animals Sciences for the care and use of labo-
ratory animals (Institute of Laboratory Animal
Resources 1996). We divided 24 rats into four
exposure groups. The rats were placed in
whole-body exposure chambers and exposed
to 0, 5, 10, or 15 cigarettes (New Paradise,
Taiwan), representing control, low, medium,
and high doses, respectively. Filtered air was
introduced into the chamber at a low rate of
200 L/min. Rats were exposed to cigarette
smoke for 30 min, twice a day, 6 days/week
for 1 month. Room temperature was main-
tained at 22–25°C, and relative humidity was
approximately 40%. After 1 month, rats were
weighed and killed. After removal from the
thorax, the hearts were cleaned with double-
distilled water and dried before weighing. The
left and right atria and the right ventricle were
then removed, and the left ventricle was
weighed. We calculated the ratios of total
heart weight and left ventricle weight to body
weight.
Hematoxylin-eosin and Masson trichrome
staining. Hearts were ﬁxed in formalin, embed-
ded in paraffin, and sectioned. Slides were
hydrated through a series of graded alcohols
(100, 95, and 75%), 15 min each. The slides
were then stained with hematoxylin and eosin
(H&E) or Masson trichrome. After gently rins-
ing with water, slides were dehydrated through
graded alcohols for 15 min each, cleared in
xylene, and coverslipped. Photomicrographs
were obtained using Zeiss Axiophot micro-
scopes (Zeiss, Oberkochen, Germany). 
Tissue extraction. Cardiac tissue extracts
were obtained by homogenizing the left ven-
tricle samples in phosphate-buffered saline
(PBS; 0.14 M NaCl, 3 mM KCl, 1.4 mM
KH2PO4, 14 mM K2HPO4) at a concentra-
tion of 1 mg tissue/10 µL PBS for 5 min. The
homogenates were placed on ice for 10 min
and then centrifuged at 12,000 rpm for
30 min. The supernatant was collected and
stored at –70°C for further experiments.
Protein contents. We determined the pro-
tein content of cardiac tissue extract using the
Bradford protein assay (Bradford 1976) using
the protein-dye kit (Bio-Rad, Richmond, CA,
USA). We used a commercially available
bovine serum albumin (Sigma Chemical, St.
Louis, MO, USA) as a standard. Changes in
optical density were monitored at 595 nm.
Zymography protease assay. We mixed the
cardiac tissue extracts (40 µg) thoroughly with
a suitable volume of PBS buffer and 4 µL dye.
We carried out gelatin zymography analysis
by loading 20 µL of the extracts on 8%
SDS-PAGE gels containing 0.1% gelatin  and
run by electrophoresis at 140 V for 2.5 hr. The
gels were washed in a 2.5% Triton X-100 solu-
tion with shaking for 30 min and then incu-
bated in 50 mL reaction buffer (40 mM
Tris-HCl, pH 8.0; 10 mM CaCl2, 0.01%
NaN3) at 37°C for 12 hr before staining with
0.25% Coomassie brilliant blue R-250 in 50%
methanol and 10% acetic acid for 1 hr.
Quantitative analysis was preformed after dis-
coloring the stain in a destaining solution (10%
acetic acid, 20% methanol) twice for 30 min.
Electrophoresis and Western blot. We pre-
pared the tissue extract samples as described
above. SDS-PAGE was carried out with 10%
polyacrylamide gels. The samples were elec-
trophoresed at 140 V for 3.5 hr and equili-
brated for 15 min in 25 mM Tris-HCl, pH
8.3, containing 192 mM glycine and 20%
(vol/vol) methanol. Electrophoresed proteins
were transferred to nitrocellulose paper
(Hybond-C Extra Supported, 0.45 µm;
Amersham, Piscataway, NJ, USA) using a
Hoefer Scientiﬁc Instruments Transphor unit
(Hoefer Scientiﬁc, San Francisco, CA, USA) at
100 mA for 14 hr. We incubated nitrocellulose
papers in blocking buffer for 2 hr at room tem-
perature and then in blocking buffer contain-
ing 100 mM Tris-HCl, pH 7.5, 0.9% (wt/vol)
NaCl, and 0.1% (vol/vol) fetal bovine serum
for 2 hr at room temperature. Monoclonal
antibodies (Santa Cruz Biotechnology, Santa
Cruz, CA, USA) were diluted 1:200 in anti-
body binding buffer containing 100 mM
Tris-HCl, pH 7.5, 0.9% (wt/vol) NaCl, 0.1%
(vol/vol) Tween-20, and 1% (vol/vol) fetal
bovine serum. Incubations were performed at
room temperature for 3.5 hr. We washed the
immunoblots three times in 50 mL blotting
buffer for 10 min and then immersed in the
second antibody solution containing alkaline
phosphatase goat anti-rabbit IgG (Promega,
Madison, WI, USA) for 1 hr and diluted
1,000-fold in binding buffer. The ﬁlters were
then washed in blotting buffer for 10 min
three times. Color development was presented
in 20 mL of a mixture consisting of 7 mg nitro
blue tetrazolium, 5 mg 5-bromo-4-chloro-3-
indolyl-phosphate, 100 mM NaCl, and 5 mM
MgCl2 in 100 mM Tris-HCl, pH 9.5. Signal
intensity of Western blots was quantitated
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Figure 1. Cardiomyopathic changes in rats exposed to different doses of SHS. Abbreviations: C, control; H,
high dose; L, low dose; M, medium dose; numbers beside the treatment represent the repetition. (A) The
heart weight (wt) to body wt ratio (mean ± SD) of rats exposed to SHS (at least five rats per group).
(B) Histopathologic analysis of cardiac tissue sections stained with H&E. Magnification: top, 100 ×; bottom,
400X; bars = 15 µm. Enlarged interstitium was observed in SHS-administered animal hearts, with the high-
dose group showing the most significant changes; arrows indicate the myocardial interstitium.
(C) Representative cross-sections with trichrome staining; fibrotic areas are stained blue. Bar = 15 µm;
magnification, 200X. Extensive fibrosis and myofibril disarray are present in hearts from SHS-treated rats,
particularly the high-dose group. Cardiac fibrosis induced by SHS is described in more detail in
the “Discussion.” Alteration of MMP-2 levels in cardiac tissues as shown by MMP-2 mRNA levels ana-
lyzed by semiquantitative RT-PCR, using GAPDH as a loading control (D) and MMP-2 activities analyzed by
zymography assay (E).
*Significantly different compared with the control group (p < 0.05).
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using a PhosphoImager (Kodak, Rochester,
NY, USA). 
RNA extraction. We extracted total RNA
using the Ultraspec RNA Isolation System
(Biotecx Laboratories, Inc., Houston, TX,
USA) according to the manufacturer’s instruc-
tions. Each heart was thoroughly homogenized
in 1 mL Ultraspec reagent/100 mg tissue using
a Polytron homogenizer (Kinematica AG,
Lucerne, Switzerland). The homogenates were
washed twice with 70% ethanol by gentle vor-
texing. RNA precipitates were then collected
by centrifugation at 12,000 × g and dried
under vacuum for 5–10 min before dissolving
in 50 µL diethylpyrocarbonate-treated water;
precipitates were then incubated at 55–60°C
for 10–15 min.
RT-PCR. Total RNA (1 µg) was reverse
transcribed and then ampliﬁed (30 cycles) by
PCR using a Super Script preamplification
system for ﬁrst-strand cDNA synthesis and Taq
DNA polymerase (Life Technologies, GIBCO
BRL, Rockville, MD, USA). RT-PCR products
(45 µL) were separated on a 1.25% low-
melting-point agarose gel (Life Technologies).
Amplimers were synthesized based on cDNA
sequences from GenBank (2004). We used the
human pHe7 gene as an internal standard.
RNA dot blotting. We used RNA dot blot-
ting for the hybridization and detection of
IGF-1 and IGF-1R mRNAs as described pre-
viously (Huang et al. 1998). The correspond-
ing digoxigenin-labeled antisense RNA probes
were prepared from pGEM-1 containing a
BamH1–EcoR1 956-bp insert consisting of
exon 3 and ﬂanking intron sequences from the
rat IGF-1 gene, and the pTRI-IGFR-human
transcription template containing a 236-bp
cDNA fragment of the human IGF-1R gene
spanning exons 8–7 (Ambion, Austin, TX,
USA).
Statistical analysis. We compared the data
between groups of animals using one-way
analysis of variance. We used Fisher’s least sig-
niﬁcant difference test to determine differences.
p-Values < 0.05 were taken as signiﬁcant.
Results
Cardiomyopathic alteration of rats adminis-
tered different doses of SHS. After 1-month
administration of different doses SHS, all rats
showed a generally healthy appearance. They
were then weighed and killed, and the hearts
were removed and weighed. We observed dark
spots in the right ventricle of SHS-treated rats,
and the ratio of whole heart weight to body
weight showed significant reduction in the
high-dose group (Figure 1A). To understand
the possible cause of the decreased heart
weight, we performed a histopathologic analy-
sis of ventricular tissue stained with H&E as
well as Masson trichrome. We found that the
ventricular myocardium of healthy controls
showed normal architecture and orderly align-
ment of myocytes with minimal interstitial
ﬁbrosis in tissues observed at both 100× and
400× magniﬁcation. In contrast, disarray with
markedly enlarged interstitium of myocytes is
evident in the SHS-administered group, and
the most significant change was observed in
the high-dose group (Figure 1B). Hearts from
SHS-treated rats stained with Masson
trichrome showed extensive fibrosis and
myoﬁbril disarray at the 200× magniﬁcation
(Figure 1C). Masson trichrome staining also
qualitatively revealed increased collagen depo-
sition at minor and moderate levels in low-
and medium-dose groups, respectively, but at
a very strong level in the high-dose group. In
addition, we evaluated the activity of matrix
metalloprotease-2 (MMP-2), a gelatinase that
can degrade extracellular matrix and that is
associated with the morphologic changes. The
treated groups had higher levels of both
MMP-2 mRNA and protein activity than did
the control group, although there was a
decline in the high-dose group (Figure 1D,E).
Changes of caspase-3 mRNA and active
protein levels in the cardiac tissues of rats.
Exposure to SHS could lead to cardiomyocyte-
apoptosis–related heart failure. In order to
identify the promotion of apoptosis, we meas-
ured mRNA and the active protein levels of the
executive apoptotic protein caspase-3. Both
mRNA and the active protein levels of treated
groups were higher than those of the controls
(Figure 2).
Alterations of component protein levels of
Fas-receptor–dependent and mitochondria-
dependent apoptotic pathways in the cardiac
tissues of rats. To further understand the
upstream signaling pathways associated with
the activation of caspase-3, we examined the
levels of the components of the Fas death-
receptor–dependent and mitochondria-
dependent/death-receptor–independent
apoptotic pathways. Compared with control
animals, both Fas mRNA and protein levels
increased in a dose-dependent manner
(Figure 3A–C). Additionally, all the treated
groups showed significantly higher levels of
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Figure 2. Activation of caspase-3 in cardiac tissues of rats. Abbreviations: C, control; H, high dose; L, low
dose; M, medium dose; numbers beside the treatment represent the repetition. (A) Semiquantitative
RT-PCR analysis of caspase-3 from left ventricles, using GAPDH as a loading control. (B) Western blot
analysis of the activated form of caspase-3 from left ventricles, using α-tubulin as a loading control.
(C) Caspase-3 shown as percent of control (mean ± SD of three independent experiments). 
**Significantly different compared with the control group (p < 0.01).
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Figure 3. Activation of Fas and caspase-8 in cardiac tissues of rats. Abbreviations: C, control; H, high dose;
L, low dose; M, medium dose; numbers beside the treatment represent the repetition. Fas activation in left
ventricles shown by (A) semiquantitative RT-PCR analysis, (B) Western blot analysis, and (C) quantitation
of signal intensity of FAS (mean ± SD of three independent experiments). Caspase-8 activation in left ven-
tricles shown by (D) Western blot analysis and (E) quantitation of the signal intensity of the activated form
of caspase-8 (mean ± SD of three independent experiments).
*Significantly different compared with the control group (p < 0.05). **Significantly different compared with the control
group (p < 0.01).
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active caspase-8 than did the control group
(Figure D,E). Conversely, there was no differ-
ence in expression of cytosolic cytochrome c
protein in any of the groups, and there was a
signiﬁcant decrease in active caspase-9 protein
level in the medium- and high-dose groups
(Figure 4A,B). Furthermore, both cardiac Bad
and BCl2 levels were signiﬁcantly higher in all
treated groups, compared with the control
group (Figure 4C,D).
Induction of IGF-1 and IGF-1R mRNA
in cardiac tissues of rats. We also examined
cell survival. Except for the mRNA level of
IGF-1R in the low-dose group, dot blotting
analysis of cardiac survival factor showed
mRNA of both IGF-1 and IGF-1R to have
significantly greater increases than in the
control group. This suggested that the sur-
vival pathway, IGF-1 signaling, might be
up-regulated in cardiac tissue of rats exposed
to SHS (Figure 5).
Discussion
In the present study, after the exposure of 5,
10, or 15 cigarettes for 30 min, twice per day
for 1 month, the rat hearts showed increased
weight loss, interstitial fibrosis, and MMP-2
activity. After the conﬁrmation of the activated
caspase-3, a marker of apoptosis development,
and the elevated levels of active caspase-8 and
Fas protein, we did not observe increased levels
of active caspase-9 or released cytochrome c in
SHS-exposed rat hearts. This indicates that
SHS-induced biologic cardiac responses associ-
ated with the activated caspase-3 may be
involved with the Fas-signaling pathway.
Furthermore, we demonstrated that cardiac
expressions of IGF-1 and IGF-1R mRNA
found by dot blotting were increased, suggest-
ing that the compensatory effect of IGF-1 sur-
vival signaling also occurred in the hearts of the
SHS-exposed rats.
Brilla et al. (1990) reported an association
between the turnover of collagens and remod-
eling of the rat ventricles. The remodeling
progresses immediately after myocardial dam-
age with an increased level of collagenases
(Janicki et al. 1995). Because MMP-2 is a
member of gelatinase-A family, this enzyme is
able to hydrolyze collagens I, IV, V, and VII
(Dollery et al. 1995). Therefore, the level of
MMP-2 might be predicted to increase during
cardiac remodeling. Weber et al. (1992)
reported that the severity of cardiac fibrosis
may become significantly apparent with the
development of remodeling by increasing
MMP activity. That is, once the heart is dam-
aged, extracellular matrix that connects cardio-
myocytes will be degenerated by increased
MMP for the adaptation of cardiomyocyte
enlargement and fibroblast invasion. After
hypertrophy, the dead apoptotic myocytes will
be replaced by collagens, which are secreted by
the invaded fibroblasts and will accumulate,
resulting in ventricular fibrosis (Anversa and
Nadal-Ginard 2002; Kim and Iwao 2000;
Pacifico and Henry 2003; Takemura and
Fujiwara 2003). The myocardial interstitial
changes resulting from increased collagen
deposition lead to cardiac stiffness and patho-
logic cardiac dysfunction (Anversa et al. 1996).
Accordingly, the accumulated collagen, an
extracellular matrix protein, will further con-
tribute to the development of heart failure
(Kim and Iwao 2000). In our study, the regis-
tered alignment of the normal myocardium
characteristics became disordered by the
administration of SHS (Figure 1B). Masson
trichrome staining also showed extensive ﬁbro-
sis and myoﬁbril disarray in the SHS-exposed
heart, with wider interstitial space and higher
expression and activity levels of MMP-2
(Figure 1B–E). These results suggest the
development of cardiac premature death char-
acterized by the distortion in myocardium
architecture and ﬁbrosis. We believe that patho-
logic cardiac dysfunction can be predicted to
occur if the experiment period is prolonged.
Additionally, the data on IGF-1 signaling up-
regulation in the present study might provide
another explanation for the occurrence of car-
diac ﬁbrosis. The up-regulated IGF-1 signaling
might promote the proliferation of noncardio-
myocytes, such as ﬁbroblasts, which may grow
to ﬁll in the space originally occupied by apop-
totic cardiomyocytes, and again result in myo-
cardial interstitial changes and cardiac ﬁbrosis
(Kim and Iwao 2000).
Apoptosis of cardiomyocytes has an impor-
tant implication on cardiac dysfunction
because of the reduced number of cardio-
myocytes per functional units. The weight loss
we found in smoking-induced rat ventricle in a
dose-dependent manner (Figure 1A) could be
associated with the progression of heart failure.
The expression levels and activity increases of
Kuo et al.
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Figure 4. Activation of proteins related to apoptotic pathways in cardiac tissues. Abbreviations: C, control; H,
high dose; L, low dose; M, medium dose; numbers beside the treatment represent the repetition. Cytosolic
cytochrome c and the activated form of caspase-9 in left ventricles shown by (A) Western blot analysis and
(B) quantitation of signal intensity of cytosolic cytochrome c and the activated form of caspase-9 (mean ± SD
of three independent experiments). Bad and BCl2 in left ventricles shown by (C) Western blot analysis and
(D) quantitation of the signal intensity of Bad and BCl2 (mean ± SD of three independent experiments).
*Significantly different compared with the control group (p < 0.05). **Significantly different compared with the control
group (p < 0.01).
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Figure 5. Induction of IGF-1 and IGF-1R gene expression in left ventricles from rats. Abbreviations: C, con-
trol; H, high dose; L, low dose; M, medium dose. (A) RNA dot blots prepared with 240 ng RNA/dot and
probed with labeled oligonucleotide probes specific for the indicated genes. 18S RNA was used as a load-
ing control. (B) Fold induction of gene expression (mean ± SD) for SHS-treated animals relative to control
from three independent experiments.
*Significantly different compared with the control group (p < 0.05).**Significantly different compared with the control
group (p < 0.01).
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caspase-3 by RT-PCR and Western blotting
(Figure 2) raise the possibility of cardio-
myocyte apoptosis. Actually, caspase-3 is an
important molecular marker of apoptotic sig-
naling in that it modulates both mitochondria-
dependent and Fas death-receptor–dependent
apoptotic pathways. Further evidence conﬁrm-
ing which of them is involved in the activation
of caspase-3 is provided by the ﬁndings of ele-
vated levels of caspase-8 and Fas, coupled with
no alteration or even reduced levels of
caspase-9 activity and cytosolic cytochrome c
in ventricles of rats exposed to SHS (Figures 3
and 4). This demonstrates that the Fas-signal-
ing pathway, but not mitochondria-dependent
pathway, is associated with the increased cas-
pase-3 level that may indicate apoptosis.
Additionally, because of the activation of the
Fas-signaling apoptotic pathway, to contend
with cell death, cardiac IGF-1 survival signal-
ing was also increased (Figure 5) in SHS-
exposed rat hearts. Furthermore, it is notable
that SHS-induced dose-dependent responses
of heart weight loss and interstitial ﬁbrosis are
not demonstrated in that of other cardiac
gene/protein levels. The results of Masson
trichrome staining showed minor to moderate
fibrosis in low- and medium-dose groups.
However, more severe ﬁbrosis responses were
observed in the high-dose group (Figure 1C).
We conjecture that apoptotic enzyme actions
are still under control in low- and medium-
dose groups. However, cells severely damaged
by high doses may be too weak to produce
enough enzymes. This makes the gene/protein
level alteration fail in a dose-dependent man-
ner in SHS-exposed hearts.
The elevated level of the proapoptotic
protein Bad was also observed in SHS-treated
rat hearts (Figure C,D). Based on the observa-
tion of the 2.3-fold enhancement of BCl2
promoter activity by IGF-1 (Pugazhenthi
et al. 1999), it is possible that the promoted
IGF-1 signaling resulted in the activation of
the antiapoptotic protein BCl2, which might
counterbalance the action of elevated pro-
apoptotic protein Bad and prohibit the release
of cytochrome c from the mitochondria.
Another important study (Makin et al. 2001)
reported that the induction of apoptosis by
Bax, whose exertions are promoted by the
translocation of Bad to mitochondria and can
cause cytochrome c release, may limit the
process of the mitochondria-dependent apop-
totic pathway in some cancer cells. Makin
et al. (2001) conjectured that some events
besides Bax oligomerization/complex forma-
tion to the mitochondria surface were absent
in the cells. Hence, the abnormality of Bax
action in these events may also have occurred
in the SHS-stimulated cardiac tissue, explain-
ing why the elevated Bad level did not result
in cytochromec release from mitochondria.
Our ﬁndings on the SHS effects in cardiac
tissue include reduction of weight, alteration
of morphology, possible progression of
remodeling, ﬁbrosis, and the apoptosis-related
effects predicted by the activation of caspase-3
and Fas death-receptor-pathway–dependent
signaling. They may be, at least partially, the
possible molecular mechanisms behind how
exposure of nonsmokers to SHS leads to the
increased risk of cardiac events reported in epi-
demiologic studies. Particularly, because
cardiomyocyte apoptosis and/or fibrosis is a
more typical end-stage condition, it is more
beneficial to alleviate these problems before
the end-stage is reached. Therefore, it would
seem appropriate to block cardiac Fas signal-
ing when considering possible agents that
might be helpful to control the development
of apoptosis and/or ﬁbrosis-related cardiac dis-
ease induced by SHS.
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In the manuscript originally published
online, there were errors in authors’ names
and affiliations; they have been corrected
here.
